Un estudio sobre el tiempo de tránsito gastrointestinal a nivel poblacional (GITTPop)
Tiempo de Tránsito Gastrointestinal a Nivel de Población: Un Estudio Transversal
The goal of this study is to investigate the baseline of gastrointestinal transit time (GITT) and explore its relationship with other health indicators in 932 healthy adult volunteers.
The main questions it aims to answer are:
What are the population-level baseline values for GITT using the blue dye method? How is GITT associated with key physiological parameters including blood metabolic markers, life style, and stool characteristics?
Participants will:
Consume a standardized blue dye muffin after overnight fasting at the research center; Offer a finger prock blood samples for metabolic profiling; Offer a saliva sample for whole exome sequencing analysis; Collect stool samples for moisture measurement; Complete detailed questionnaires on diet, lifestyle, and bowel habits; Record the time of first blue stool appearance to determine GITT.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
This explorative study is designed as a cross-sectional investigation aimed at establishing population-level reference values for gastrointestinal transit time (GITT). Adult participants from the general population will undergo GITT measurement using the blue-dye method. This muffin contains blue colorant that cannot be absorbed; after ingestion, it passes through the entire gastrointestinal tract and is eventually excreted in feces. Following a two-day lifestyle standardization period (including dietary and activity guidance) to minimize potential confounding effects on gastrointestinal motility, participants will attend a clinical visit where they will ingest a blue muffin. GITT will be determined by measuring both the time interval between ingestion of the blue muffin and the first appearance of blue-colored stool, and the duration from its first appearance to its complete disappearance.
The blue muffin method has been well-established in previous research for GITT assessment. Building upon the methodology developed by Berry et al., we will introduce stricter pre-test condition controls (includes dietary advice and lifestyle recommendations) and optimized the blue muffin formulation. These improvements allow for reliable measurement with a single muffin administration, which has been evaluated through KU Leuven Health Pass in a large sample size(S-70168).
To investigate potential determinants and correlates of GITT, we will collect biochemical parameters, fecal moisture, and resting metabolic rate. We will collect saliva samples for WGS to identify key genetic variants associated with GITT and use these findings to develop a genetic risk score. Additionally, participants will complete 24-h diet record and health questionnaires assessing bowel movement, physical activity habits, stress levels, sleep quality and hydration condition for subsequent correlation analyses.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Christophe Matthys
- Número de teléfono: +32 016342655
- Correo electrónico: christophe.matthys@uzleuven.be
Copia de seguridad de contactos de estudio
- Nombre: Wei Li
- Número de teléfono: +32 016344539
- Correo electrónico: wei.li2@kuleuven.be
Ubicaciones de estudio
-
-
Flemish Brabant
-
Leuven, Flemish Brabant, Bélgica, 3000
- Reclutamiento
- Department of Chronic Diseases and Metabolism
-
Contacto:
- Wim Janssens
- Número de teléfono: +32 016252111
- Correo electrónico: wim.janssens@kuleuven.be
-
Contacto:
- Evelyne van Etten
- Número de teléfono: +32 016330855
- Correo electrónico: evelyne.vanetten@kuleuven.be
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Healthy volunteers from the Flanders region who volunteered to participate in the research
Descripción
Inclusion Criteria:
- 18-65 years old
- 18.5 kg/m² ≤ BMI ≤ 25 kg/m² or BMI ≥ 30 kg/m² (people with normal weight or obesity)
- Provision of informed consent to participate.
Exclusion Criteria:
- Gastrointestinal conditions which may affect nutrient absorption or gastric emptying, including coeliac disease, Crohn's disease, previous resection of the small intestine other than bariatric surgery, gastroparesis;
- Using medications which effect gastric motility (e.g., domperidone, erythromycin, metoclopramide, prucalopride, opiates, loperamide, …)
- The ingredients of blue muffins include gluten, nuts, baking powder, sugar, vanilla extract and sunflower oil. Participants with allergies to these ingredients;
- Current diagnosis of cancer;
- Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Child-Pugh B or C, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4;
- Immobility;
- Neuromuscular degenerative conditions associated with muscular atrophy, such as myasthenia gravis, muscular dystrophies, fibromyalgia, or multiple Sclerosis;
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: CROSS_SECTIONAL
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Adult participants
Healthy adult participants without serious gastrointestinal diseases |
Participants will consume a regular muffin containing blue dye |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Gastrointestinal transit time
Periodo de tiempo: From enrollment to the end of study at 2 weeks
|
Calculate the transit time by the recorded muffin consuming time, first blue stool appearance time and last blue stool appearance time |
From enrollment to the end of study at 2 weeks
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Height (cm)
Periodo de tiempo: baseline
|
Measured using a height meter, in centimeters. |
baseline
|
|
Weight (kg)
Periodo de tiempo: baseline
|
Measuring using a scale, in kg. |
baseline
|
|
BMI
Periodo de tiempo: baseline
|
weight and height will be combined to report BMI in kg/m^2 |
baseline
|
|
Blood glucose (mmol/L)
Periodo de tiempo: baseline
|
Measure blood glucose by CardioChek Plus in mmol/L |
baseline
|
|
Fat mass (kg)
Periodo de tiempo: baseline
|
Using Bodystat quadscan 4000 to measure fat mass (kg) |
baseline
|
|
Lean body mass(kg)
Periodo de tiempo: baseline
|
Using Bodystat quadscan 4000 to measure lean body mass (kg) |
baseline
|
|
Fat percentage (%)
Periodo de tiempo: baseline
|
Using Bodystat quadscan 4000 to measure fat% |
baseline
|
|
Total cholesterol (mmol/L)
Periodo de tiempo: baseline
|
Measuring by Mission cholesterol Meter in mmol/L |
baseline
|
|
HDL-C (mmol/L)
Periodo de tiempo: baseline
|
Measuring by Mission cholesterol Meter in mmol/L |
baseline
|
|
LDL-C (mmol/L)
Periodo de tiempo: baseline
|
Measuring by Mission cholesterol Meter in mmol/L |
baseline
|
|
Triglyceride (mmol/L)
Periodo de tiempo: baseline
|
Measuring by Mission Cholesterol Meter in mmol/L |
baseline
|
|
Food record
Periodo de tiempo: 2 days after study
|
Participants record their 24-h diets through smartphone application |
2 days after study
|
|
Stool form
Periodo de tiempo: baseline
|
Stool form will be evaluated by Bristol Stool Form Scale, the score is from 1 to 7, with values closer to the middle indicating more ideal stool shape. |
baseline
|
|
Hydration status
Periodo de tiempo: baseline
|
Hydration status will be rated from 1 to 8 by Urine color chart, with higher numbers indicating that the body needs more water. |
baseline
|
|
Perceived level of stress
Periodo de tiempo: baseline
|
The10-item Perceived Stress will be used to measures an individual's perceived level of stress over the past month. The total score ranges from 0 to 40. A higher score indicates a greater perceived level of stress. |
baseline
|
|
Sleep quality
Periodo de tiempo: baseline
|
Pittsburgh Sleep Quality Index will be used to assess subjective sleep quality over the past month. The total score ranges from 0 to 21. A higher score indicates poorer sleep quality. |
baseline
|
|
Activity level
Periodo de tiempo: baseline
|
The Baecke Physical Activity Questionnaire will be used to assess daily habitual physical activity, with a particular focus on work-related and exercise-related activities. It does not produce a single total score, but rather scores on three dimensions, each typically ranging from 1 to 5. On each dimension, a higher score indicates a higher level of physical activity in that area. Therefore, for assessing activity levels, a higher score is generally better. |
baseline
|
|
Whole genome sequencing (WGS)
Periodo de tiempo: baseline
|
The genetic risk score will be calculated by summing the number of GITT-associated alleles carried by each participant, weighted by their estimated effect sizes. As the number and weights of the included variants will be determined during the analysis, the score does not have a predefined numerical range. The score will be standardized to a mean of 0 and a standard deviation of 1. A higher score will indicate a stronger genetic predisposition to the GITT phenotype of interest; it does not necessarily represent a better or worse health outcome. |
baseline
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- S70908
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .